AQR Capital Management
TNXP icon

AQR Capital Management’s Tonix Pharmaceuticals TNXP Stock Holding History

AQR Capital Management’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.22M Buy
161,208
+141,188
+705% +$2.17M ﹤0.01% 2279
2025
Q4 		$313K Buy
+20,020
New +$369K ﹤0.01% 3150
2022
Q1 		– Sell
-2
Closed -$366K – 2294
2021
Q4 		$366K Buy
+2
New +$636K ﹤0.01% 1925
2021
Q3 		– Hold
0
– – – 2224
2021
Q2 		– Hold
0
– – – 2076
2015
Q1 		– Hold
0
– -$89K – 2309
2014
Q4 		– Hold
0
– – – 2460
2014
Q3 		– Hold
0
– – – 2455

Other funds holding TNXP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JHC
Jones Hill Capital New York $466M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

AQR Capital Management's TNXP Position: Q1 2026 in Review

AQR Capital Management increased its Tonix Pharmaceuticals (TNXP) stake by 705% in Q1 2026, buying an estimated $2.17M and bringing the position to 161,208 shares worth $2.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2279.

AQR Capital Management first reported a position in TNXP in Q4 2021 and has held it in 3 quarters since. 81 funds tracked by Wall St. Rank hold TNXP as of Q1 2026.

  • AQR Capital Management held 161,208 shares of Tonix Pharmaceuticals worth $2.22M as of Q1 2026.
  • AQR Capital Management bought 141,188 Tonix Pharmaceuticals shares in Q1 2026, an estimated $2.17M.
  • Tonix Pharmaceuticals made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2279 holding.
  • AQR Capital Management first reported a position in Tonix Pharmaceuticals in Q4 2021 and has held it in 3 quarters since.
  • 81 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.